D. E. Shaw & Co., Inc. Tg Therapeutics, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $173,376 - $392,000	11,200 New	11,200 $278,000
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $250,090 - $613,704	28,100 Added 128.31%	50,000 $974,000
Q1 2018 May 15, 2018	BUY	$8.7 - $16.8 $190,529 - $367,920	21,900 New	21,900 $311,000

269

87.7M

2.72M

1.74M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $2.84B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.